General Information of the Compound
| Compound ID |
CP0943099
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Oxo-2,3-dihydro-pyridine-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H42N8O5
|
||||||||||||||||||
| Molecular Weight |
594.717
|
||||||||||||||||||
| Canonical SMILES |
N=C(N)NCCC[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1C=CC=NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H42N8O5/c31-25(39)23(17-19-9-3-1-4-10-19)37-28(42)22(14-8-16-35-30(32)33)36-29(43)24(18-20-11-5-2-6-12-20)38-27(41)21-13-7-15-34-26(21)40/h1,3-4,7,9-10,13,15,20-24H,2,5-6,8,11-12,14,16-18H2,(H2,31,39)(H,36,43)(H,37,42)(H,38,41)(H4,32,33,35)/t21?,22-,23-,24-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UATHQCQVJFAHDZ-NSBVFQKPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound